PR Newswire Clinical TrialsOriginal article
Caristo Diagnostics to Highlight New Findings Reinforcing the Science of Its Coronary Inflammation and Plaque Analysis Technologies at SCCT 2026
ConferenceFAI-ScorePositive
AI Analysis
Summary
Caristo Diagnostics will present findings on its coronary inflammation and plaque analysis technologies at SCCT 2026, with three of six Young Investigator Award-nominated abstracts utilizing the company's technologies, including a new application of FAI-Score on non-contrast cardiac CT.
Importance:3/10
Sentiment:
0.40
conference presentationdiagnostic technologycardiac imagingresearch recognitionaward nomination
Read the original article
Published by PR Newswire Clinical Trials on July 8, 2026 11:21 AM
